The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis

Journal of Molecular Medicine

Volumn 91, Issue 5, 2013, Pages 573-586

  Kim, Kyung Hyun ^a   Park, Ji Hyun ^a   Lee, Woo Ram ^a   Park, Jae Shin ^a   Kim, Hyun Chul ^b   Park, Kwan Kyu ^a  

^a Catholic University of Daegu   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

Decoy oligodeoxynucleotide; Epithelial mesenchymal transition; NF B; Renal interstitial fibrosis; Sp1

Indexed keywords

CHIMERIC PROTEIN; I KAPPA B; OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR SP1; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MOUSE; NONHUMAN; URETER OBSTRUCTION;

ANIMALS; BIOLOGICAL MARKERS; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MOLECULAR TARGETED THERAPY; MYOFIBROBLASTS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; URETERAL OBSTRUCTION;

EID: 84879082481     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-012-0972-2     Document Type: Article

References (44)

1. Li MX, Liu BC (2007) Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chin Med J (Engl) 120:1925-1930
2. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ (1997) Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 50:123-127
3. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM (1997) Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transplant 12:43-50
4. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS (1996) Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148:1169-1180
5. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG (2002) Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350
6. Yang J, Liu Y (2001) Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475
7. Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784
8. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY (1999) Transforming growth factor-beta regulates tubular epithelial- myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467
9. Bascands JL, Schanstra JP (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 68:925-937
10. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW (2006) Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 290:F4-F13
11. Wang X, Zhou Y, Tan R, Xiong M, He W, Fang L, Wen P, Jiang L, Yang J (2010) Mice lacking the matrix metalloproteinase-9 gene reduce renal interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 299:F973-F982
12. Li Y, Yang J, Dai C, Wu C, Liu Y (2003) Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503-516
13. Zeisberg M, Strutz F, Muller GA (2001) Renal fibrosis: an update. Curr Opin Nephrol Hypertens 10:315-320
14. Guijarro C, Egido J (2001) Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59:415-424
15. Kassimatis TI, Nomikos A, Giannopoulou I, Lymperopoulos A, Moutzouris DA, Varakis I, Nakopoulou L (2010) Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury. Ren Fail 32:243-253
16. Klahr S, Morrissey J (2002) Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 283:F861-F875
17. Chevalier RL (2006) Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol 2:157-168
18. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R (1993) In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43:682-692
19. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R (1999) Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene 18:6888-6895
20. Tomita N, Kashihara N, Morishita R (2007) Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin Exp Nephrol 11:7-17
21. Kim KH, Lee ES, Cha SH, Park JH, Park JS, Chang YC, Park KK (2009) Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Exp Mol Pathol 86:114-120
22. Park JH, Jo JH, Kim KH, Kim SJ, Lee WR, Park KK, Park JB (2009) Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. J Gene Med 11:824-833
23. Ahn JD, Kim CH, Magae J, Kim YH, Kim HJ, Park KK, Hong S, Park KG, Lee IK, Chang YC (2003) E2F decoy oligodeoxynucleotides effectively inhibit growth of human tumor cells. Biochem Biophys Res Commun 310:1048-1053
24. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, Wang L, Zhu CF (2004) In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65:834-845
25. Miwa K, Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Oishi M, Kataoka K, Ohgi S, Ogihara T et al (2005) Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Ther 12:1109-1118
26. Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K, Ogihara T, Kaneda Y, Morishita R (2007) Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Circ Res 101:1175-1184
27. Goodarzi H, Najafabadi HS, Oikonomou P, Greco TM, Fish L, Salavati R, Cristea IM, Tavazoie S (2012) Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature 485:264-268
28. Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179
29. Jimenez SA, Varga J, Olsen A, Li L, Diaz A, Herhal J, Koch J (1994) Functional analysis of human alpha 1(I) procollagen gene promoter. Differential activity in collagen-producing and -nonproducing cells and response to transforming growth factor beta 1. J Biol Chem 269:12684-12691
30. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F (1997) Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. J Biol Chem 272:19738-19745
31. Inagaki Y, Truter S, Ramirez F (1994) Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269:14828-14834
32. Infantino V, Convertini P, Iacobazzi F, Pisano I, Scarcia P, Iacobazzi V (2011) Identification of a novel Sp1 splice variant as a strong transcriptional activator. Biochem Biophys Res Commun 412:86-91
33. Chae YM, Park KK, Lee IK, Kim JK, Kim CH, Chang YC (2006) Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction. Gene Ther 13:430-439
34. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79:319-326
35. Gu L, Ni Z, Qian J, Tomino Y (2007) Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. Nephron Exp Nephrol 106:e1-e10
36. Goumenos DS, Brown CB, Shortland J, el Nahas AM (1994) Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 9:1418-1425
37. Hewitson TD, Wu HL, Becker GJ (1995) Interstitial myofibroblasts in experimental renal infection and scarring. Am J Nephrol 15:411-417
38. Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1-12
39. Kassimatis TI, Nomikos A, Giannopoulou I, Lymperopoulos A, Moutzouris DA, Varakis I, Nakopoulou L (2010) Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury. Ren Fail 32:243-253
40. Choi J, Park SY, Joo CK (2007) Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. Investig Ophthalmol Vis Sci 48:2708-2718
41. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA (1997) A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 272:G281-G288
42. Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H (2007) NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 26:711-724
43. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG (1995) Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405
44. Barnes PJ, Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071